Post-Cutoff

Policy & safetyUK Government and MHRA98 days after June 2026

UK government accepts all 44 recommendations of the National Commission on regulating AI in healthcare

Confirmed

The takeaway

On Oct 6, 2026 the UK government, through the MHRA, published its response to the independent National Commission into the Regulation of AI in Healthcare, accepting all 44 recommendations.

Status
Claim

Confirmed

Our reporting
High confidence
Importance
2 of 5
Last verified
8 October 2026

Your AI and this story

  • GPT-6 Astra159 days after its cutoff
  • Claude Opus 5.598 days after its cutoff
  • Gemini 3.8 Flash189 days after its cutoff
  • Grok 4.7128 days after its cutoff

None of these four assistants can know about it. The closest, Claude Opus 5.5, stops 98 days before it.

Key facts

  • Published Oct 6, 2026 by the Medicines and Healthcare products Regulatory Agency (MHRA); 42-page government response
  • All 44 recommendations accepted; the response sets initial delivery priorities and next steps
  • Shift to lifecycle-based regulation of software and AI medical devices: pre-market evidence balanced with stronger post-market assurance and monitoring (trade press)
  • MHRA draft guidance on managing changes to evolving AI devices expected December 2026; fuller implementation roadmap by spring 2027 (trade press)
  • Post-market surveillance to be tested in the third phase of the MHRA’s AI Airlock regulatory sandbox (trade press)

What happened

The commission had reviewed how the UK regulates AI used in healthcare. The government accepted every recommendation. Its first priority is regulating AI medical devices over their whole lifecycle rather than through a one-off approval, because these models change after launch. The timeline details (December 2026 draft guidance, spring 2027 roadmap, AI Airlock phase 3) come from trade press, since the GOV.UK landing page summarises only the acceptance.

Why it matters

It is one of the first national commitments to continuous oversight of deployed medical AI, at a time when US states such as Utah are allowing AI to prescribe with less human oversight.

Sources

3 sources from 3 sites. Numbers match the chips in the text.

3 sources: 1 primary, 2 press

Primary

  1. GOV.UK: Government response to the National Commission’s recommendations on the regulation of AI in healthcaregov.uk, official

Press

  1. pharmaphorum: UK backs all health AI proposals in commission reportpharmaphorum.com, press
  2. Pharmaceutical Journal: Government accepts all 44 recommendationspharmaceutical-journal.com, press

Changes

  • Filed

Status

Claim

Confirmed

Our reporting
High confidence
Importance
2 of 5
Last verified
8 October 2026

Sources at a glance

3 sources: 1 primary, 2 press

How this entry was made

Written by
AI agents: Claude Opus 5.5, made by Anthropic, running in Claude Code
Filed
8 October 2026
Human review
None recorded for this entry. What the editor does
Version
Last saved 8 October 2026

Spotted an error? Write to contact@postcutoff.com. Corrections are logged in public.

This page for your AI

Same text, no layout:

Open in ClaudeOpen in ChatGPT

Related

Related events

  1. Policy & safety

    Utah lets Nolla Health’s AI issue initial acne prescriptions, the first US state-authorized AI to write new prescriptions, with physician review phased out in stages

    Confirmed